Chembio Diagnostics Inc is a US-based company that develops, manufactures, and commercializes point-of-care diagnostic tests that detect infectious diseases. The products of the company include rapid tests for the detection of HIV 1/2 antibodies and a multiplex rapid test for the detection of HIV and syphilis antibodies. The company offered rapid medical tests that are offered in Africa, Asia, Europe, and the Middle East, Latin America and the United States, of which key revenue is derived from Latin America.
| Website: | www.chembio.com |
| Email: | investor@chembio.com |
| Main Phone: | +1 631 924-1135 |
| Address: | 555 Wireless Boulevard |
| State: | NY |
| City / Town: | Hauppauge |
| Country: | USA |
| Postal Code: | 11788 |
| Exchange: | NSC |
| CEO: | Richard L. Eberly |
| Employees: | 324 |
| NAICS: | In-Vitro Diagnostic Substance Manufacturing(325413) |
These blood tests can quickly identify disease-fighting antibodies in people who already have been infected but may have had mild symptoms or none at all.
In the U.S., the medical device and diagnostics industry has been burdened with conflicting regulations that have delayed commercialization and complicated reimbursement. In this interview, Brian
Corrections of 3% to 5% are not uncommon in bull markets. Whether one becomes a bigger correction depends on what news hits the market when it is about to recover from one of these corrections.
At www.ValuEngine.com we show that the Medical sector 12.6% overvalued with the medical Products industry 10.4% undervalued. All 12 stocks in today’s table have complete ValuEngine data and have
Chembio Diagnostics Inc is a US-based company that develops, manufactures, and commercializes point-of-care diagnostic tests that detect infectious diseases. The products of the company include rapid tests for the detection of HIV 1/2 antibodies and a multiplex rapid test for the detection of HIV and syphilis antibodies. The company offered rapid medical tests that are offered in Africa, Asia, Europe, and the Middle East, Latin America and the United States, of which key revenue is derived from Latin America.
| Website: | www.chembio.com |
| Email: | investor@chembio.com |
| Main Phone: | +1 631 924-1135 |
| Address: | 555 Wireless Boulevard |
| State: | NY |
| City / Town: | Hauppauge |
| Country: | USA |
| Postal Code: | 11788 |
| Exchange: | NSC |
| CEO: | Richard L. Eberly |
| Employees: | 324 |
| NAICS: | In-Vitro Diagnostic Substance Manufacturing(325413) |
These blood tests can quickly identify disease-fighting antibodies in people who already have been infected but may have had mild symptoms or none at all.
In the U.S., the medical device and diagnostics industry has been burdened with conflicting regulations that have delayed commercialization and complicated reimbursement. In this interview, Brian
Corrections of 3% to 5% are not uncommon in bull markets. Whether one becomes a bigger correction depends on what news hits the market when it is about to recover from one of these corrections.
At www.ValuEngine.com we show that the Medical sector 12.6% overvalued with the medical Products industry 10.4% undervalued. All 12 stocks in today’s table have complete ValuEngine data and have
| Last Price 4.24 | Change $ -0.19 | Change % -4.29 | Tick N/A |
| Bid 4.18 | Bid Size 2,200.00 | Ask 4.22 | Ask Size 3,700.00 |
| Open 4.31 | High 4.49 | Low 4.04 | Prev Close 4.43 |
| Last Trade | Volume 6 mi | 52 Wk Hi 15.90 | 52 Wk Low 2.25 |
| Market Cap 85.5 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 20,168,503.00 | EPS (TTM) -0.93 | PE Ratio N/A | Exchange NCM |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 7 | 19 |
| Number of Buys | 2 | 6 |
| Number of Sells | 5 | 13 |
| Net Activity | -14082 | 5304 |
| Last 10 Buys | Shares |
|---|---|
| Neil A. Goldman | 1,000 |
| Peter T. Kissinger | 1,000 |
| Sharon Klugewicz | 1,000 |
| Gary Meller | 1,000 |
| Katherine L. Davis | 1,000 |
| Katherine L. Davis | 1,000 |
| Gary Meller | 1,000 |
| Katherine L. Davis | 1,000 |
| Katherine L. Davis | 1,000 |
| Katherine L. Davis | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Sharon Klugewicz | 1,000 |
| Javan Esfandiari | 1,000 |
| Javan Esfandiari | 1,000 |
| Javan Esfandiari | 1,000 |
| Richard J. Larkin | 1,000 |
| Javan Esfandiari | 1,000 |
| Javan Esfandiari | 1,000 |
| Lawrence A. Siebert | 1,000 |
| Lawrence A. Siebert | 1,000 |
| Lawrence A. Siebert | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 13.5 | 13.5 | 13.5 | 13.5 |
| Low Target Price Estimate | 10 | 10 | 10 | 10 |
| Mean Target Price Estimate | 11.17 | 11.17 | 11.17 | 11.17 |
| Standard Deviation | 2.02 | 2.02 | 2.02 | 2.02 |
| Date of Most Recent Estimate | 05/15/18 | 05/15/18 | 05/15/18 | 05/15/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-15 |
| 8-K | Report of unscheduled material events or corporate changes. | 23 | 2018-05-30 |
| 8-K | Report of unscheduled material events or corporate changes. | 6 | 2018-05-25 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-18 |
| 3 | Initial statement of beneficial ownership of securities | 1 | 2018-05-16 |
| 8-K | Report of unscheduled material events or corporate changes. | 6 | 2018-05-16 |
| 8-K | Report of unscheduled material events or corporate changes. | 8 | 2018-05-09 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 32 | 2018-05-09 |
| 8-K | Report of unscheduled material events or corporate changes. | 5 | 2018-04-27 |
| 8-K | Report of unscheduled material events or corporate changes. | 6 | 2018-04-26 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1 | 1 | 1 | 1 |
© 2020 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
Gathering Data... Please wait